ArticleEuropean radiology experimental2026
Preoperative prediction of tumor budding grade in rectal cancer by combining APT histogram analysis and ADC MRI.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTumor budding (TB) is a histopathological marker of aggressive behavior and poor prognosis in rectal cancer (RC), yet not reliably evaluated preoperatively. We assessed whether histogram features from amide proton transfer-weighted (APTw) imaging and apparent diffusion coefficient (ADC) maps could serve as noninvasive biomarkers for preoperative TB grade prediction. MATERIALS AND
methodsThis retrospective study included 204 patients with RC from June 2023 to May 2025, divided into a training cohort (n = 133) and a validation cohort (n = 71) using a temporal split. All patients underwent preoperative APTw and diffusion-weighted imaging, and TB grade was determined histopathologically. Histogram features were extracted from whole-tumor volumes on APTw and ADC maps. Feature selection used a machine learning-based classifier, followed by univariate and multivariate logistic regression to identify independent predictors. SHapley Additive exPlanations (SHAP) were applied for interpretability, and a nomogram integrating histogram and clinical variables was constructed.
resultsFive key histogram features (ADC-90%, ADC-Minimum, ADC-Range, APTw-10%, and APTw-Median) were selected. The histogram model achieved areas under the curve (AUROCs) of 0.85 (95% confidence interval [CI]: 0.79-0.92) and 0.86 (95% CI: 0.78-0.95) in the training and validation cohorts. SHAP analysis identified ADC-90% and ADC-Minimum as the most influential predictors. The combined model with histogram and clinical factors showed improved performance, with AUROCs of 0.88 (95% CI: 0.82-0.94) and 0.87 (95% CI: 0.79-0.96).
conclusionAPTw and ADC histogram features can independently predict TB grade in RC. The combined model, integrating both histogram and clinical features, further enhanced preoperative predictive accuracy. RELEVANCE STATEMENT: This study investigates the role of imaging biomarkers in the preoperative stratification of RC, with the potential to enhance clinical decision-making and improve patient outcomes by providing more accurate, noninvasive prognostic information. KEY POINTS: A histogram-based model using APTw and ADC maps can predict TB grade in RC preoperatively. A combined model integrating clinical factors and histogram features improves predictive accuracy. This interpretable, contrast-free method provides a practical tool for clinicians to personalize treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.